儿童癫痫的长程管理

doi:10.12372/jcp.2023.22e0020

Abstract

Abstract:

The high incidence of epilepsy in children seriously affects the quality of life of children and their families. The treatment of epilepsy is characterized by long course of treatment and many influencing factors, so long-term management is very important for improving prognosis and quality of life. There is a big gap in the management level of children epilepsy in different areas of China, which needs to be further standardized. This article introduces the long-term management of epilepsy in children.

Key words: epilepsy, management, child

ZHU Dengna, NIU Guohui. Long-term management of epilepsy in children[J].Journal of Clinical Pediatrics, 2023, 41(3): 235-240.

References 35

[1]	中华医学会儿科学分会神经学组. 儿童癫痫长程管理专家共识[J]. 中华儿科杂志, 2013, 51(9): 699-703.
[2]	Casetta I, Pugliatti M, Faggioli R, et al. Incidence of childhood and adolescence epilepsy: a community-based prospective study in the province of Ferrara and in Copparo, Italy, 1996-2005[J]. Eur J Neurol, 2012, 19(2): 312-316. doi: 10.1111/j.1468-1331.2011.03506.x pmid: 21906212
[3]	Beghi E. The epidemiology of epilepsy[J]. Neuro-epidemiology, 2020, 54(2): 185-191.
[4]	Fleeman N, Bradley PM. Care delivery and self-management strategies for children with epilepsy[J]. Cochrane Database Syst Rev, 2018, 3: D6245.
[5]	Ferro MA, Avery L, Fayed N, et al. Child- and parent-reported quality of life trajectories in children with epilepsy: a prospective cohort study[J]. Epilepsia, 2017, 58(7): 1277-1286. doi: 10.1111/epi.13774 pmid: 28485850
[6]	Chen Z, Brodie MJ, Liew D, et al. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study[J]. JAMA Neurol, 2018, 75(3): 279-286. doi: 10.1001/jamaneurol.2017.3949 pmid: 29279892
[7]	Hall-Flavin DK, Winner JG, Allen JD, et al. Using a pharmacogenomic algorithm to guide the treatment of depression[J]. Transl Psychiatry, 2012, 2: e172. doi: 10.1038/tp.2012.99
[8]	Gabr WM, Shams ME. Adherence to medication among outpatient adolescents with epilepsy[J]. Saudi Pharm J, 2015, 23(1): 33-40. doi: 10.1016/j.jsps.2014.05.003 pmid: 25685041
[9]	O' Rourke G, O' Brien JJ. Identifying the barriers to antiepileptic drug adherence among adults with epilepsy[J]. Seizure, 2017, 45: 160-168. doi: S1059-1311(16)30321-1 pmid: 28063375
[10]	von Gaudecker JR, Buelow JM, Miller WR, et al. Social determinants of health associated with epilepsy treatment adherence in the United States: a scoping review[J]. Epilepsy Behav, 2021, 124: 108328. doi: 10.1016/j.yebeh.2021.108328
[11]	中国抗癫痫协会精准医学与药物不良反应监测专业委员会. 抗癫痫药物所致不良反应的研究进展[J]. 癫痫杂志, 2019, 5(4): 280-284.
[12]	Kaushik S, Chopra D, Sharma S, et al. Adverse drug reactions of anti-epileptic drugs in children with epilepsy: a cross-sectional study[J]. Curr Drug Saf, 2019, 14(3): 217-224. doi: 10.2174/1574886314666190311112710 pmid: 30854975
[13]	Shi YW, Min FL, Zhou D, et al. HLA-A*24: 02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions[J]. Neurology, 2017, 88(23): 2183-2191. doi: 10.1212/WNL.0000000000004008
[14]	Lamberink HJ, Otte WM, Geleijns K, et al. Antiepileptic drug withdrawal in medically and surgically treated patients: a meta-analysis of seizure recurrence and systematic review of its predictors[J]. Epileptic Disord, 2015, 17(3): 211-228. doi: 10.1684/epd.2015.0764 pmid: 26292909
[15]	齐自娟, 黎振声, 董李, 等. 抗癫痫药物减停及停药后癫痫复发风险的研究进展[J]. 解放军医学院学报, 2021, 42(9): 983-987.
[16]	Campistol J. Epilepsy in inborn errors of metabolism with therapeutic options[J]. Semin Pediatr Neurol, 2016, 23(4): 321-331. doi: S1071-9091(16)30036-5 pmid: 28284393
[17]	van Karnebeek C, Sayson B, Lee J, et al. Metabolic evaluation of epilepsy: a diagnostic algorithm with focus on treatable conditions[J]. Front Neurol, 2018, 9: 1016. doi: 10.3389/fneur.2018.01016 pmid: 30559706
[18]	Rheims S, Auvin S. Attention deficit/hyperactivity disorder and epilepsy[J]. Curr Opin Neurol, 2021, 34(2): 219-225. doi: 10.1097/WCO.0000000000000903 pmid: 33464761
[19]	Perucca P, Scheffer IE, Kiley M. The management of epilepsy in children and adults[J]. Med J Aust, 2018, 208(5): 226-233. pmid: 29540143
[20]	中华儿科杂志编辑委员会, 中华医学会儿科学分会, 神经学组中国抗癫痫协会. 生酮饮食疗法在癫痫及相关神经系统疾病中的应用专家共识[J]. 中华儿科杂志, 2019, 57(11): 820-825.
[21]	Sondhi V, Agarwala A, Pandey RM, et al. Efficacy of ketogenic diet, modified atkins diet, and low glycemic index therapy diet among children with drug-resistant epilepsy: a randomized clinical trial[J]. JAMA Pediatr, 2020, 174(10): 944-951. doi: 10.1001/jamapediatrics.2020.2282
[22]	Singh SP, Sankaraneni R, Antony AR. Evidence-based guidelines for the management of epilepsy[J]. Neurol India, 2017, 65(Supple): S6-S11.
[23]	Orosz I, McCormick D, Zamponi N, et al. Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children[J]. Epilepsia, 2014, 55(10): 1576-1584. doi: 10.1111/epi.12762 pmid: 25231724
[24]	中国抗癫痫协会神经调控专业委员会, 中国医师协会神经调控专业委员会, 中华医学会神经外科分会神经生理学组. 迷走神经刺激治疗药物难治性癫痫的中国专家共识[J]. 癫痫杂志, 2021, 7(3): 191-196.
[25]	Starnes K, Miller K, Wong-Kisiel L, et al. A review of neurostimulation for epilepsy in pediatrics[J]. Brain Sci, 2019, 9(10): 283. doi: 10.3390/brainsci9100283
[26]	Mortazavi A, Elliott RS, Phan TN, et al. Responsive neurostimulation for the treatment of medically refractory epilepsy in pediatric patients: strategies, outcomes, and technical considerations[J]. J Neurosurg Pediatr, 2021: 1-8.
[27]	Aaberg KM, Bakken IJ, Lossius MI, et al. Comorbidity and childhood epilepsy: a nationwide registry study[J]. Pediatrics, 2016, 138(3): e20160921. doi: 10.1542/peds.2016-0921
[28]	Park KJ, Kim MJ, Yum MS, et al. Clinical and neuropsychological characteristics of children with epilepsy and attention-deficit/hyperactivity disorder[J]. Seizure, 2021, 91: 325-331. doi: 10.1016/j.seizure.2021.06.022 pmid: 34274892
[29]	Lukmanji S, Manji SA, Kadhim S, et al. The co-occurrence of epilepsy and autism: a systematic review[J]. Epilepsy Behav, 2019, 98(Pt A): 238-248. doi: S1525-5050(19)30494-9 pmid: 31398688
[30]	Nobili L, Beniczky S, Eriksson SH, et al. Expert opinion: managing sleep disturbances in people with epilepsy[J]. Epilepsy Behav, 2021, 124: 108341. doi: 10.1016/j.yebeh.2021.108341
[31]	邵晓丽, 胡佳妮, 姚银萍, 等. 遗传性癫痫伴热性惊厥附加症患儿的疫苗接种风险分析[J]. 中华神经医学杂志, 2020, 19(2): 176-180.
[32]	杭州市疾病预防控制中心, 苏州市疾病预防控制中心, 上海市疾病预防控制中心, 等. 特殊健康状态儿童预防接种专家共识之八—癫痫与预防接种[J]. 中国实用儿科杂志, 2019, 34(2): 82-84.
[33]	刘家琪, 杨逸昊, 王胜, 等. 新型冠状病毒疫苗与癫痫相关研究进展[J]. 癫痫杂志, 2021, 7(4): 327-334.
[34]	徐保平, 魏庄, 卢根, 等. 儿童新型冠状病毒疫苗预防接种20问[J]. 中华实用儿科临床杂志, 2021, 36(18): 1368-1372.
[35]	尹延肖, 余年, 狄晴. 癫痫发作诱因的研究现状[J]. 癫痫杂志, 2017, 3(4): 310 -314.

Long-term management of epilepsy in children

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References 35

Related Articles 15

Metrics

Comments

Recommended 0

[1]	LIN Jinfeng, CHEN Yi, DENG Yan, FENG Ai, HUANG Juan, CHEN Lizhu, XIE Jingqi, NIE Xiaojing. A comparative study on the detection of anti-Nephrin antibodies in children's nephrotic syndrome by chemiluminescence method and cell-based assay [J]. Journal of Clinical Pediatrics, 2026, 44(8): 682-689.
[2]	ZHENG Fangyuan, WANG Miao, DING Mingming, LU Aidong, JIA Yueping, ZENG Huimin, ZHANG Leping. Next-generation sequencing identified gene variants and their prognostic impact in pediatric Philadelphia chromosome positive acute lymphoblastic leukemia [J]. Journal of Clinical Pediatrics, 2026, 44(8): 690-697.
[3]	ZHANG Xiao, FANG Hongjun, KUANG Xiaojun, WANG Lijuan, WU Zhao, JIANG Sha, LI Pei, WU Liwen. Analysis of the clinical and electrophysiological characteristics of atonic seizures in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 698-704.
[4]	WANG Mengqian, YANG Hui. Case series analysis of 13 intestinal Behcet’s syndrome in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 705-711.
[5]	WU Xirong, GAO Qi, GUO Siyuan, YIN Qingqin, QIN Qiang, YIN Ju, JIAO Anxia, CHEN Chenghao, WU Di, WANG Bei, DUAN Xiaomin, PENG Yun, XU Baoping, GAO Liwei. Clinical characteristics and prognosis of pulmonary mucormycosis in children with diabetes mellitus [J]. Journal of Clinical Pediatrics, 2026, 44(8): 712-720.
[6]	HAN Yanan, GE Lanlan, CUI Jieyuan. A case report of branchio-oto-renal syndrome caused by EYA1 gene variant with a 6-year follow-up [J]. Journal of Clinical Pediatrics, 2026, 44(8): 721-726.
[7]	SHI Jiayi, GAO Chunlin, JIA Lili, LU Yunyun, SUN Tao, ZHU Xiaodong, XIA Zhengkun, ZHANG Pei. Phenotypic characteristics and prognostic analysis of a pedigree with childhood isolated nephrotic syndrome caused by compound heterozygous mutations in the COQ2 gene [J]. Journal of Clinical Pediatrics, 2026, 44(8): 727-732.
[8]	Rachel Rosen, Osvaldo Borrelli, Christophe Faure, Katja Karrento, Usha Krishnan, Samuel Nurko, Nathalie Rommel, Alan Silverman, Michiel van Wijk, Marc Benninga (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: upper gastrointestinal disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 595-608.
[9]	Carlo Di Lorenzo, Miguel Saps, Bruno P. Chumpitazi, Shaman Rajindrajith, Annamaria Staiano, Nikhil Thapar, Miranda van Tilburg, Carlos Velasco-Benítez, Arine Vlieger (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: lower and biliary disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 609-621.
[10]	LI Xufeng, TANG Haoxun, LI Xingjun, ZHANG Lize, GAO Chenqing, ZHAO Shunying, LIU Jianhua. Clinical characteristics, chest CT imaging phenotypes, and their correlation with prognosis in 76 children with Chlamydia pneumoniae pneumonia [J]. Journal of Clinical Pediatrics, 2026, 44(7): 622-627.
[11]	WANG Zhen, SHAO Jingbo, ZHANG Na, XIA Min, ZHU Jiashi, DU Chengkan, LI Hong. Factors influencing long-term recurrence in pediatric acute lymphoblastic leukemia patients with low-risk disease at initial diagnosis: a five-year follow-up analysis of 254 cases from a single center [J]. Journal of Clinical Pediatrics, 2026, 44(7): 628-635.
[12]	GUO Xuemei, XUE Yao, WANG Yongren, RONG Liucheng, FANG Yongjun, LIN Rufeng. Clinical features and prognosis of childhood acute myeloid leukemia with CBFA2T3::GLIS2 fusion [J]. Journal of Clinical Pediatrics, 2026, 44(7): 636-643.
[13]	YANG Lijun, FU Dongxia, CUI Yan, YANG Junmei, ZHANG Liming. Clinical manifestation and genetic analysis of CHARGE syndrome caused by CHD7 gene variation [J]. Journal of Clinical Pediatrics, 2026, 44(7): 644-650.
[14]	HU Yan, YANG Fan, LIANG Aimin, MAO Meng. Identification and management of faltering growth in children: insights from the 13th International Conference on Nutrition and Growth [J]. Journal of Clinical Pediatrics, 2026, 44(6): 485-488.
[15]	LIU Ziyao, WANG Congying, WANG Hongmao, ZHANG Mingming, XU Yingjie, LAI Jianming, NIU Wenquan, LI Xiaohui. Early differentiation of Kawasaki disease with joint symptoms and systemic juvenile idiopathic arthritis with Kawasaki disease-like symptoms: a single-center retrospective study [J]. Journal of Clinical Pediatrics, 2026, 44(6): 489-498.